EUCTR2015-001928-29-FR进行中（未招募）1 期
Phase II randomized trial comparating two concomitant administration of radiotherapy with cisplatin in patients with not operated or inoperable squamous cell carcinoma of the head and neck or with recurrence high-risk in adjuvant postoperative treatment. - CisFRad
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- GORTEC
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 92
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Abraxane and Gemcitabine versus Gemcitabine alone in locally advanced unresectable pancreatic cancer.124 locally advanced unresectable pancreatic cancer patients will be randomized in a 1:1 ratio to receive abraxane/gemcitabine (arm A) or gemcitabine alone (arm B), as first-line chemotherapyEUCTR2013-002973-23-ITFondazione GISCAD
招募中
2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90
尚未招募
2 期
A phase II Randomized controlled trial A comparison of short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancersCTRI/2024/04/065785Tata Memorial Centre
招募中
1 期
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapyMetastatic or locally advanced leiomyosarcomaMedDRA version: 21.1Level: PTClassification code: 10024189Term: Leiomyosarcoma Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10024191Term: Leiomyosarcoma metastatic Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10024192Term: Leiomyosarcoma non-metastatic Class: 10029104CTIS2024-513820-40-00Italian Sarcoma Group100
进行中（未招募）
1 期
A randomized comparative phase II trial evaluating the capacity of the dualcombination doravirine/raltegravir to maintain virological success in HIV-1infected patients with an HIV-RNA plasma viremia below 50 copies/mL under acurrent antiretroviral regimen.HIV-1 INFECTIONEUCTR2019-004195-19-ITCentre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS)150